GSA CAPITAL PARTNERS LLP

Position in LAB — Standard Biotools Inc.

CIK 1362033 LONDON, X0

Position in LAB

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$973,899

+$648,706 QoQ

Shares Held

1,187,682

+236.0% QoQ

Ownership

0.303%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#28

of 143 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $34,102,577 across 41 Medical Devices names. LAB ranks #13 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDT	Medtronic plc	68,541	$5,361,962
2	NPCE	NeuroPace Inc	115,535	$1,835,851
3	QTRX	Quanterix Corp	410,252	$1,772,288
4	PODD	Insulet Corp	11,310	$1,721,947
5	INFU	InfuSystem Holdings, Inc	160,439	$1,548,236
6	VMD	Viemed Healthcare, Inc.	127,591	$1,454,537
7	BSX	Boston Scientific Corp	32,095	$1,369,814
8	DXCM	Dexcom Inc	19,820	$1,334,877

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$973,899	1,187,682	+236.0%	Shares	Sole	2026-08-06
2026-03-31	$325,193	353,471	+647.8%	Shares	Sole	2026-05-08
2025-12-31	$60,500	47,266	-84.6%	Shares	Sole	2026-02-06
2025-06-30	$367,784	306,487	-49.6%	Shares	Sole	2025-07-22
2025-03-31	$657,348	608,656	+369.2%	Shares	Sole	2025-05-08
2024-12-31	$227,034	129,734	+27.8%	Shares	Sole	2025-02-07
2021-12-31	$397,856	101,494	+131.2%	Shares	Sole	2022-02-14
2021-09-30	$289,333	43,905	-58.5%	Shares	Sole	2021-11-12
2021-03-31	$478,451	105,852	+152.4%	Shares	Sole	2021-05-10
2020-12-31	$251,664	41,944	-49.4%	Shares	Sole	2021-02-03
2020-09-30	$615,969	82,903	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.